| Name | ADB-PINACA |
|---|
| Formal Name | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide |
|---|
| SMILES | O=C(NC(C(N)=O)C(C)(C)C)C1=NN(CCCCC)C2=C1C=CC=C2 |
|---|
| InChI Key | FWTARAXQGJRQKN-UHFFFAOYSA-N |
|---|
| InChI Code | InChI=1S/C19H28N4O2/c1-5-6-9-12-23-14-11-8-7-10-13(14)15(22- 23)18(25)21-16(17(20)24)19(2,3)4/h7-8,10-11,16H,5-6,9,12H2,1-4H3,(H2,20,24)(H,21,25) |
|---|
| Description | ADB-PINACA is an emerging designer drug that has been found in synthetic cannabinoid samples. The molecule combines a 1-amino-3,3-dimethyl-1-oxobutan-2-yl (ADB) with a 1-pentyl-1H-indazole-3-carboxamide (PINACA). It differs from AB-PINACA by the replacement of the iso-propyl group with a tert-butyl group. Very little is known about the pharmacological activity of ADB-PINACA in humans or other animals. |
|---|
Status |
Verified |
|---|
| Submitted | 2013-09-01 |
|---|
| Submitted By | Cayman Chemical
Georgia Bureau of Investigation, Coastal Regional Laborator, Savannah, GA
Georgia Bureau of Investigation, Headquarters Laboratory, Decatur, GA |
|---|
| Published | 2013-10-28 |
|---|
| Contact | Paul D. Kennedy, PhD. at Cayman Chemical |
|---|
| Product Details | Link |
|---|
Monograph |
Download the ADB-PINACA Monograph |
|---|
|
|
